Successful Treatment of Primary and Disseminated Human Lung Cancers by Systemic Delivery of Tumor Suppressor Genes Using an Improved Liposome Vector
Open Access
- 1 March 2001
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 3 (3), 337-350
- https://doi.org/10.1006/mthe.2001.0266
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growthGene Therapy, 1999
- Characterization of Cationic Liposome-Mediated Gene TransferIn Vivoby Intravenous AdministrationHuman Gene Therapy, 1997
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Histochemical Staining Following LacZ Gene Transfer Underestimates Transfection EfficiencyHuman Gene Therapy, 1997
- Intracavitary Liposome-Mediated p53 Gene Transfer into Glioblastoma with Endogenous Wild-Type p53in VivoResults in Tumor Suppression and Long-Term SurvivalBiochemical and Biophysical Research Communications, 1997
- Factors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNature Biotechnology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Systemic Gene Therapy with p53 Reduces Growth and Metastases of a Malignant Human Breast Cancer in Nude MiceHuman Gene Therapy, 1995
- Stable Expression of the Wild-Typep53Gene in Human Lung Cancer Cells after Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1993
- The p53 tumour suppressor geneNature, 1991